OCTN2-targeted nanoparticles for oral delivery of paclitaxel: differential impact of the polyethylene glycol linker size on drug delivery in vitro, in situ, and in vivo
After the 6month followup period, nearly 8 in 10 patients reduced baseline body weight by at least 5%, nearly half reduced body weight 10% or more, and almost onefifth reduced body weight by at least 15% from baseline
Short answer: Nonot without talking to your doctor
Funding This study was not supported by any sponsor or funder
doi: 10.1016/S0091-6749(99)70215-0 66 WuG
MTT assay The number of viable cells was measured with the 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide (MTT, SigmaAldrich, USA) assay (Hansen et al